Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jon Infante

Showing results (101-110 of 145) with videos related to

Pageof 15
Sort By:
The Lancet. Neurology|May 28, 2013
Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline dataHeike Jacobi, Kathrin Reetz, Sophie Tezenas du Montcel, et al.
The Lancet. Neurology|August 22, 2020
Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort studyHeike Jacobi, Sophie Tezenas du Montcel, Sandro Romanzetti, et al.
Journal of Neurology|November 3, 2022
The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factorsHolger Hengel, Peter Martus, Jennifer Faber, et al.
Neuropathology and Applied Neurobiology|February 17, 2023
A standardised protocol for blood and cerebrospinal fluid collection and processing for biomarker research in ataxiaMagda M Santana, Laetitia S Gaspar, Maria M Pinto, et al.
Medrxiv : the Preprint Server for Health Sciences|February 26, 2024
Neuroradiological findings in GAA-<i>FGF14</i> ataxia (SCA27B): more than cerebellar atrophyShihan Chen, Catherine Ashton, Rawan Sakalla, et al.
EMBO Molecular Medicine|June 9, 2020
Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and miceCarlo Wilke, Eva Haas, Kathrin Reetz, et al.
Neurology. Genetics|February 25, 2025
Involvement of the Superior Cerebellar Peduncles in GAA-<i>FGF14</i> AtaxiaShihan Chen, Catherine Ashton, Rawan Sakalla, et al.
European Journal of Neurology|April 28, 2022
Tau and neurofilament light-chain as fluid biomarkers in spinocerebellar ataxia type 3Hector Garcia-Moreno, Mercedes Prudencio, Gilbert Thomas-Black, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 23, 2010
Self-rated health status in spinocerebellar ataxia--results from a European multicenter studyTanja Schmitz-Hübsch, Mathieu Coudert, Paola Giunti, et al.
Acta Neuropathologica Communications|July 19, 2025
Influence of ATXN2 intermediate CAG repeats, 9bp duplication and alternative splicing on SCA3 pathogenesisMarilena Lauerer, Jennifer Faber, Nicolas Casadei, et al.
Pageof 15

Showing results (101-110 of 145) with videos related to

Sort By:
Pageof 15
The Lancet. Neurology|May 28, 2013
Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline dataHeike Jacobi, Kathrin Reetz, Sophie Tezenas du Montcel, et al.
The Lancet. Neurology|August 22, 2020
Conversion of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 to manifest ataxia (RISCA): a longitudinal cohort studyHeike Jacobi, Sophie Tezenas du Montcel, Sandro Romanzetti, et al.
Journal of Neurology|November 3, 2022
The frequency of non-motor symptoms in SCA3 and their association with disease severity and lifestyle factorsHolger Hengel, Peter Martus, Jennifer Faber, et al.
Neuropathology and Applied Neurobiology|February 17, 2023
A standardised protocol for blood and cerebrospinal fluid collection and processing for biomarker research in ataxiaMagda M Santana, Laetitia S Gaspar, Maria M Pinto, et al.
Medrxiv : the Preprint Server for Health Sciences|February 26, 2024
Neuroradiological findings in GAA-<i>FGF14</i> ataxia (SCA27B): more than cerebellar atrophyShihan Chen, Catherine Ashton, Rawan Sakalla, et al.
EMBO Molecular Medicine|June 9, 2020
Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and miceCarlo Wilke, Eva Haas, Kathrin Reetz, et al.
Neurology. Genetics|February 25, 2025
Involvement of the Superior Cerebellar Peduncles in GAA-<i>FGF14</i> AtaxiaShihan Chen, Catherine Ashton, Rawan Sakalla, et al.
European Journal of Neurology|April 28, 2022
Tau and neurofilament light-chain as fluid biomarkers in spinocerebellar ataxia type 3Hector Garcia-Moreno, Mercedes Prudencio, Gilbert Thomas-Black, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 23, 2010
Self-rated health status in spinocerebellar ataxia--results from a European multicenter studyTanja Schmitz-Hübsch, Mathieu Coudert, Paola Giunti, et al.
Acta Neuropathologica Communications|July 19, 2025
Influence of ATXN2 intermediate CAG repeats, 9bp duplication and alternative splicing on SCA3 pathogenesisMarilena Lauerer, Jennifer Faber, Nicolas Casadei, et al.
Pageof 15